L’objectif de l’outil OSPSANTE est de capturer, de suivre, d’agréger et de diffuser des informations sur les produits de Nutrition et de lutte contre le paludisme, la PF, la SMI et le VIH, pour soutenir la prise de décision basée sur des éléments de preuve au Mali. L’outil OSPSANTE aidera le pays et les organisations internationales, telles que l’USAID, l’ONUSIDA, l’OMS, le Fonds mondial et autres parties prenantes à améliorer les prévisions, la planification de l’approvisionnement et les achats pour permettre la disponibilité continue des produits de Nutrition et de lutte contre le paludisme, de la PF, de la SMI, et du VIH. Le présent guide de l’utilisateur permettra d’utiliser facilement l’outil OSPSANTE. Il fournit des conseils pas à pas pour accéder à l’outil OSPSANTE et générer des rapports.
Archive | Guidance DocumentRSS feed for this section
There has been a long‐recognized need of Central Medical Stores Depot (CMSD) staff for a complete collection of documents representing the up‐to‐date warehouse management
standard operating procedures (SOPs) of CMSD: there was no such resource capturing all the
operational procedures, circulars, registers, office orders, and so on used in the different sections
involved in CMSD’s logistical activities. In answer to this need, CMSD management has taken the initiative to develop a single volume containing all the required documents they have been adopted into existing procedures over the years of operation.
The objective of the National Guideline on the Pharmacovigilance System in Bangladesh is to guide health care providers (HCPs) and other key actors in the health and pharmaceutical sectors on the operations of the PV system. This document gives an overview of what PV is, how to detect and classify ADRs, and the structural organization of the system in Bangladesh. It also describes the reporting system to the NPC and expected outcomes. The document aims to help expand the roles and responsibilities of stakeholders in the country’s PV system to identify, analyze, and minimize the risks associated with pharmaceutical products. It also promotes better and broader use of PV data for patient safety.
The Philippines National TB Program’s (NTP) laboratory network strategic plan (LNSP) aims to improve access to quality laboratory services, including establishing new facilities, adopting new diagnostic technologies, and strengthening the laboratory systems. The implementation of laboratory network (LNW) strengthening plans and the performance of the LNW require a comprehensive monitoring of activities to detect problems, document results (performance), and gather lessons from the process. However, many program managers find monitoring difficult to implement because of the lack of knowledge, skills, and operational support, especially for field visits. A contributing factor is management’s weak appreciation of the value of monitoring for program management and improvement. This document aims to provide guidance to health workers who are tasked with monitoring the LNW’s status and performance. In this document, we provide the readers with practical tips on how to monitor—from preparation, data collection, data management, and reporting to a list of indicators to guide data collection.
The director of the Department of Pharmacy, Medicines, and Diagnostics (DPMED) wishes to adopt suitable software to strengthen the registration system for medicines and other health products. Although computerization yields improvements in the management of regulatory information, its effectiveness will largely depend on the presence of adequate medicines registration procedures and the system’s overall compliance with regional and international standards. This rapid evaluation thus seeks to analyze and understand Benin’s regulatory information management system for medicines registration, make appropriate recommendations, and propose an action plan based on emerging outcomes.
What Gets Defined, Gets Measured: A Definition and Framework for Pharmaceutical Systems Strengthening
A presentation by Helena Walkowiak, Principal Technical Advisor for SIAPS, on December 6 2017.
Pharmaceutical management considerations for expanded coverage of essential health services and financial protection programs
The UN adoption of the SDGs in 2015 signaled a strong commitment of member countries to the expanded access to essential health service agenda and definitively recognized the critical role of medicines in achieving UHC. The SDGs call for countries to “achieve universal health coverage, including financial risk protection, access to quality essential health care services and access to safe, effective, quality and affordable essential medicines and vaccines for all”. This paper seeks to highlight the key functional areas of pharmaceutical management, the critical components of the pharmaceutical system, and the management considerations needed to facilitate the attainment of UHC targets.
This inventory is a selected list of resources and interventions that support antimicrobial resistance (AMR) containment. The objective of this inventory is to provide a list of key resources, tools, and interventions that create or strengthen systems that are necessary to improve antimicrobial use and AMR containment. Along with the full references, links are provided directly to the documents or to sites from where the documents can be downloaded. The intention is to periodically update the inventory as new resources, tools, and evidence-based interventions become available.
The training materials in this compilation were developed by technical advisors from SIAPS. The training was conducted in November 2014. This will serve as a guide for trainings in LIMU. Sessions follow the spectrum of information management from data organization, analysis, and interpretation to the utilization of information for information sharing, planning, and decision making. A stakeholder analysis, which is important to prepare and disseminate audience-specific reports, is also included.
The user guide primarily serves as a reference in reporting an adverse event (AE) through PViMS. It also serves to guide reporters and investigators in completing a correct and accurate AE report. This guide outlines the key data needed, starting from the initial alert to the completion of an AE report in PViMS.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]